Patent US2564824A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6029671A Expired / Lapsed US ⏱️ 0.0 years remaining

System and methods for performing endovascular procedures

Assignee: Edwards Lifesciences LLC
•
Filing: 1996-05-22
•
Granted: 2000-02-29
•
Expires: 2016-05-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A system for inducing cardioplegic arrest and performing an endovascular procedure within the heart or blood vessels of a patient. An endoaortic partitioning catheter has an inflatable balloon which occludes the ascending aorta when inflated. Cardioplegic fluid may be infused through a lumen of the endoaortic partitioning catheter to stop the heart while the patient's circulatory system is supported on cardiopulmonary bypass. One or more endovascular devices are introduced through an internal lumen of the endoaortic partitioning catheter to perform a diagnostic or therapeutic endovascular procedure within the heart or blood vessels of the patient. Surgical procedures such as coronary artery bypass surgery or heart valve replacement may be performed in conjunction with the endovascular procedure while the heart is stopped. Embodiments of the system are described for performing: fiberoptic angioscopy of structures within the heart and its blood vessels, valvuloplasty for correction of valvular stenosis in the aortic or mitral valve of the heart, angioplasty for therapeutic dilatation of coronary artery stenoses, coronary stenting for dilatation and stenting of coronary artery stenoses, atherectomy or endarterectomy for removal of atheromatous material from within coronary artery stenoses, intravascular ultrasonic imaging for observation of structures and diagnosis of disease conditions within the heart and its associated blood vessels, fiberoptic laser angioplasty for removal of atheromatous material from within coronary artery stenoses, transmyocardial revascularization using a side-firing fiberoptic laser catheter from within the chambers of the heart, and electrophysiological mapping and ablation for diagnosing and treating electrophysiological conditions of the heart.

Inventors

  • 👤 John H. Stevens
  • 👤 William S. Peters
  • 👤 Wesley D. Sterman
  • 👤 Hanson S. Gifford, III

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:44
CPC Classifications
A; A61; A61M; A61M39/00; A61M39/02; A61M39/0247; A61B; A61B17/00; A61B17/00234; A61B17/02; A61B17/0218; A61B17/04; A61B17/0469; A61B17/06; A61B17/06061; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1492; A61B90/00; A61B90/50; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2427; A61M1/00; A61M1/36; A61M1/3621; A61M1/3653; A61M1/3659; A61M25/00; A61M25/0021; A61M25/0041; A61M25/01; A61M25/0105; A61M25/0133; A61M25/0152; A61M25/06; A61M25/0662; A61M25/10; A61M25/1011; A61B17/0467; A61B17/28; A61B17/29; A61B17/2909; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/0237; A61B2017/0243; A61B2017/047; A61B2017/0472; A61B2017/0474; A61B2017/0475; A61B2017/2926; A61B2017/2932; A61B2017/2943; A61B17/30; A61B2017/306; A61B17/34; A61B17/3403; A61B2017/3405; A61B2017/348; A61B2017/3492; A61B2018/00053; A61B2018/00214; A61B2018/0022; A61B2018/00232; A61B2018/0025; A61B2018/00261; A61B2018/00273; A61B2018/00291; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00363; A61B2018/00392; A61B2018/00571; A61B2018/00577; A61B90/36; A61B90/37; A61B2090/378; A61B2090/3782; A61B2090/3784; A61M1/3623; A61M25/0023; A61M25/0026; A61M25/003; A61M2025/0031; A61M2025/004; A61M25/0067; A61M25/0074; A61M25/0075; A61M2025/0076; A61M2025/0078; A61M25/02; A61M2025/028; A61M2025/1043; A61M2025/1047; A61M2025/1052; A61M2025/1077; A61M2025/1095; A61M2202/00; A61M2202/04; A61M2202/0468; A61M2202/047; A61M2205/00; A61M2205/11; A61M2205/33; A61M2205/3331; A61M2205/3344; A61M2205/3355; A61M2205/36; A61M2205/366; A61M2210/00; A61M2210/12; A61M2210/125; A61M2210/127; A61M25/0125; A61M25/1002

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 203 words
A method for performing an endovascular procedure on a patient, the method comprising steps of: a) placing an elongated aortic occlusion catheter at a location within the patient's ascending aorta, the aortic occlusion catheter having a proximal end, a distal end, and an expandable member, the expandable member of the aortic occlusion catheter being movable to an expanded shape which is sized and configured to substantially occlude a passageway in the patient's ascending aorta downstream of the ostia of the coronary arteries, the aortic occlusion catheter also including a lumen having an outlet; b) expanding the expandable member of the aortic occlusion catheter within the patient's ascending aorta to substantially completely occlude the passageway therein downstream of the ostia of the patient's coronary arteries and without occluding said ostia thereby blocking blood flow through the aorta; c) placing a coronary catheter having a proximal end, a distal end and an expandable member through the lumen of the aortic occlusion catheter until the distal end of the coronary catheter exits the lumen of the aortic occlusion catheter; d) directing the coronary catheter into one of the patient's coronary arteries; and e) expanding the expandable member of the coronary catheter within the patient's coronary artery.
Claim 2
Independent Claim 203 words
A method for performing an endovascular procedure on a patient, the method comprising steps of: a) placing an elongated aortic occlusion catheter at a location within the patient's ascending aorta, the aortic occlusion catheter having a proximal end, a distal end, and an expandable member, the expandable member of the aortic occlusion catheter being movable to an expanded shape which is sized and configured to substantially occlude a passageway in the patient's ascending aorta downstream of the ostia of the coronary arteries, the aortic occlusion catheter also including a lumen having an outlet; b) expanding the expandable member of the aortic occlusion catheter within the patient's ascending aorta to substantially completely occlude the passageway therein downstream of the ostia of the patient's coronary arteries and without occluding said ostia thereby blocking blood flow through the aorta; c) placing a coronary catheter having a proximal end, a distal end and an expandable member through the lumen of the aortic occlusion catheter until the distal end of the coronary catheter exits the lumen of the aortic occlusion catheter; d) directing the coronary catheter into one of the patient's coronary arteries; and e) expanding the expandable member of the coronary catheter within the patient's coronary artery.

References Cited (Backward Citations)

US33569A Cited
US3730185A Cited
US3874388A Cited
US4000739A Cited
US4195637A Cited
US4323071A Cited
US4323071B1 Cited
US4621636A Cited
US4315511A Cited
US4574781A Cited
US4290427A Cited
US4273128A Cited
US4545390A Cited
US4490421A Cited
US4538622A Cited
US4522212A Cited
US4589412A Cited
US5026366A Cited
US4781186A Cited
US4762129A Cited
US4762129B1 Cited
US4740047A Cited
US4660571A Cited
US4616653A Cited
EP0218275A1 Cited
US4699147A Cited
US4787388A Cited
US4664120A Cited
US4771774A Cited
US4669469A Cited
US4794931A Cited
USRE33569E Cited
US5000185A Cited
US4748982A Cited
US5000743A Cited
US4988356A Cited
US5041126A Cited
US4796629A Cited
US4917097A Cited
US4788975B1 Cited
US4788975A Cited
US4874089A Cited
US4854325A Cited
US5195956A Cited
US4890611A Cited
US4883460A Cited
US4924863A Cited
US4909252A Cited
US5242437A Cited
US5011469A Cited
US4917089A Cited
US5071425A Cited
US5055024A Cited
US4960134A Cited
US4856516A Cited
US5140987A Cited
US5040548A Cited
US5061273A Cited
US5037392A Cited
US5029588A Cited
US4976690A Cited
US5071424A Cited
US5156610A Cited
US5282484A Cited
US5211651A Cited
US5104393A Cited
US5024234A Cited
US5178625A Cited
US5147353A Cited
US5267955A Cited
US5368603A Cited
US5188634A Cited
US5125896A Cited
US5380316A Cited
US5389096A Cited
US5167233A Cited
US5163935A Cited
US5312344A Cited
US5295958A Cited
US5242438A Cited
US5264260A Cited
US5190046A Cited
US5327889A Cited
US5433700A Cited
WO1994016625A1 Cited
US5368037A Cited
US5366456A Cited
US5354294A Cited
US5458574A Cited
US5451207A Cited
US5456694A Cited
US5478309A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-02-28 2003-08-30 2004-02-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-02-28 2007-08-30 2008-02-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-02-28 2011-08-30 2012-02-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag